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Introduction: Kidney involvement in non-Hodgkin lymphoma is recognized but mostly diagnosed following a diagnosis
of lymphoma. We describe a rare case of mantle cell lymphoma, a B-cell-type non-Hodgkin lymphoma, first presenting
with immune complex glomerulonephritis.
Case presentation: We report the case of a 58-year-old Sri Lankan man who presented with gross hematuria. Further
investigation revealed bicytopenia with splenomegaly and elevated serum creatinine. He had a renal biopsy, which
revealed acute immune complex glomerulonephritis with interstitial inflammation. Results from an initial bone marrow
biopsy and blood imaging were inconclusive. Three months later his renal function had deteriorated and a lymph node
biopsy revealed mantle cell lymphoma. Within three months of initiating chemotherapy, his renal function returned to
normal levels and remained normal at one year of follow-up.
Conclusions: It is important to have a high degree of suspicion when patients present with acute immune complex
glomerulonephritis with no other identifiable cause, because it could be the first presentation of a non-Hodgkin
lymphoma such as mantle cell lymphoma.
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The kidney is a fascinating organ that, with its complex
architecture and physiology, can be the first site of clinical
disease manifestation in many systemic disorders. Systemic
disorders such as vasculitic disorders, connective tissue dis-
orders, hematological malignancies, and many solid organ
malignancies, as well as systemic infections, are known to
have renal manifestations. Similarly, non-Hodgkin lymph-
oma (NHL) can also have renal involvement. Over the last
few decades the incidence and survival of patients with
lymphomas, especially NHL, have increased, making its
different pathological manifestations more important
[1]. Kidney involvement can occur in many ways in NHL.
Symptoms can be related to obstruction, drug-related
nephrotoxicity, direct infiltration of NHL, or development* Correspondence: rajithaasa55@gmail.com
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manifest as a paraneoplastic syndrome [1].
We describe a rare case of B-cell NHL mantle cell
lymphoma (MCL) that first presented with acute immune
complex-mediated glomerulonephritis.Case presentation
A 58-year-old previously well Sri Lankan man was ad-
mitted to our general medical unit with two episodes of
gross hematuria with no frothy urine, dysuria, colicky
abdominal pain or reduction in urine output. He had no
preceding history of illness, fever, any other bleeding di-
athesis, or any history suggestive of a connective tissue
disease. Our patient was mildly pale with mild spleno-
megaly and an elevated blood pressure of 150/90mmHg,
but rest of the physical examination was normal. Initial
laboratory investigations revealed an elevated serum cre-
atinine of 2.9mg/dL (normal range: 0.7 to 1.3mg/dL). A
urinary microscopic examination was significant withtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 2 Renal biopsy (×400 magnification). Focal interstitial
lymphocytic infiltrate present. Focal tubular atrophy and interstitial
fibrosis with periglomerular fibrosis in these foci are seen. Red cells,
protein, and granular casts are seen.
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were dysmorphic and his protein level was 600mg/dL.
His blood leucocyte count was 5800/μL (normal range:
4000 to 11,000/μL), hemoglobin was 8.6g/dL (normal range:
11 to 16g/dL), and platelet count was 124,000/μL (normal
range: 150,000 to 450,000/μL). His erythrocyte sedi-
mentation rate was 20mm/h, his level of C-reactive pro-
tein was 1.1mg/L (normal range: 0 to 5mg/L), and serum
albumin was 3.3g/dL (normal range: 3.6 to 5.5g/dL).
An ultrasound examination of our patient’s abdomen
revealed normal-sized kidneys with increased echogenicity
with mild splenomegaly.Blood film was reported as sug-
gestive of anaemia of chronic disorder. In view of the bicy-
topenia and mild splenomegaly with significant hematuria,
we performed a renal biopsy and a bone marrow biopsy.
Results from the bone marrow biopsy showed no evidence
of marrow infiltration by leukemia, lymphoma, myeloma
or secondary deposits. The specimen from the renal bi-
opsy (Figures 1 and 2) had 14 glomeruli, seen on the
formalin-fixed paraffin sections. The glomeruli showed
a mild diffuse increase in mesangial cells and matrix, and
occasional tuft adhesions. Occasional foci of endocapillary
proliferation were seen. The capillary basement mem-
branes were normal. There were no crescents. We found
focal infiltrates of lymphocytes in the interstitium. There
were red cell and granular casts. We also noted occasional
foci with tubular atrophy, interstitial fibrosis, and periglo-
merular sclerosis.
Eight glomeruli were seen on frozen sections for im-
munofluorescence studies. Direct immunofluorescence
staining showed fine granular deposits of immunoglobu-
lin (Ig) G (3+) and complement 3 (4+) in capillaries in
all glomeruli, and IgM (2+) in the capillaries and
mesangium in two glomeruli segmentally. There was noFigure 1 Renal biopsy (×200 magnification). Diffuse increase in
mesangial cells and matrix. Occasional neutrophils seen. Occasional
foci of endocapillary proliferation seen. Focal parietal epithelial cell
hyperplasia with occasional tuft adhesions. Capillaries are thickened
but no double contouring or spikes were seen.positive staining for IgA . We did not perform electron
microscopy because it was not available at our institution.
Overall, this renal histology was consistent with immune
complex-mediated acute glomerular nephritis.
Following this initial presentation our patient defaulted
on follow-up. Three months later, he presented with bilat-
eral ankle edema with periorbital swelling. He also com-
plained of loss of appetite but had no other constitutional
symptoms. An examination revealed mild pallor, a left-side
discrete axillary lymph node, and moderate splenomegaly.
Investigations demonstrated worsening of his renal func-
tion, with serum creatinine of 3.18mg/dL and a urine pro-
tein to creatinine ratio of 1432mg/g. A urinary microscopic
examination revealed 180 to 200 red blood cells per high
power field, of which 40% were dysmorphic, along with
red cell casts and coarse granular casts. An ultrasound
examination of his kidneys revealed normal-sized kidneys
(left 13.1cm; right 11.1cm) with increased echogenicity.
His blood leucocyte count was 2900/μL, hemoglobin was
8.8g/dL, and his platelet count was 104,000/μL. Serologic
test results for hepatitis B and C, and human immunodefi-
ciency virus were negative, as was a Venereal Disease
Research Laboratory test. Tests for antinuclear antibody
and antineutrophil cytoplasmic antibody were negative.
His complement levels for both C3 and C4 were normal,
with a C3 level of 115.2mg/dL (normal range: 90 to
180mg/dL) and a C4 level of 27mg/dL (normal range:
10 to 40mg/dL). Serum cryoglobulins were not detected.
Serum protein electrophoresis did not show evidence of a
monoclonal gammopathy and myeloma screening was
negative. His lactate dehydrogenase level was 404.9U/L.
We performed an axillary lymph node biopsy, which
showed sections of his lymph node with an effaced archi-
tecture, diffusely infiltrated by a monotonous population
of small lymphoid cells (Figure 3). These cells showed
Figure 3 Lymph node biopsy (×100). Sections of the lymph node
showed an effaced architecture, and were diffusely infiltrated by a
monotonous population of small lymphoid cells.
Figure 5 Lymph node biopsy (×140). CD23 stain highlighted nodular
aggregates of follicular dendritic cells. The tumor cells were negative
for CD23.
Abeysekera et al. Journal of Medical Case Reports  (2015) 9:115 Page 3 of 4strong membrane staining with CD20. Cyclin D1 was
strongly expressed in >90% of the tumor cells (Figure 4).
His Ki67 index was 10%. A CD23 stain highlighted nodu-
lar aggregates of follicular dendritic cells (Figure 5). The
tumor cells were negative for CD23. These findings led to
a diagnosis of B-cell NHL MCL.
Therefore a final diagnosis of NHL with immune
complex-mediated glomerulonephritis was made and our
patient referred for further oncological management.
His oncological management involved a regimen of
rituximab, cyclophosphamide, doxorubicin, vincristine, and
prednisolone (R-CHOP). Follow-up at three months
showed complete normalization of his renal function to
a serum creatinine of 1.2mg/dL (normal range: 0.7 to
1.3mg/dL) and a normal urine full report (protein - trace;
red cells - nil). One year after chemotherapy, his renal
function remained normal (serum creatinine 1.0mg/dL)Figure 4 Lymph node biopsy (×100). Cyclin D1 was strongly expressed
in >90% of tumor cells.with a normal full blood count (white cell count 6100/μL,
hemoglobin 13.2g/dL, platelet count 234,000/μL) and a
serum albumin level of 3.9g/dL.
Discussion
Lymphomas are a type of tumor involving the immune
system, of which NHL constitutes around 90% [2]. The
other 10% consists of Hodgkin lymphoma. Lymphoma is
the fifth most frequently diagnosed cancer in the UK [2].
According to the most recent World Health Organization
classification of tumors of hemopoietic and lymphoid
tissues published in 2008, NHLs are broadly divided into
B-cell, T-cell and natural killer-cell lymphoma [2]. MCL is
a distinct subtype of B-cell NHL. It is recognized as a
highly aggressive lymphoma subtype that can present
very late in its disease course [3].
Glomerulonephritis (GN) in NHL is a rare phenomenon
and the type of disease can vary widely [4]. Minimal
change disease, focal segmental glomerulosclerosis, mem-
branous GN, membranoproliferative GN, mesangioproli-
ferative GN, IgA nephropathy, crescentic GN and fibrillary
GN are some of the histopathological types that have been
reported in the world literature [5,6]. Considering this
heterogeneous morphology, GN poses a great diagnostic
challenge for the clinician. Clinical presentation can vary
markedly, to include proteinuria, microscopic hematuria,
impaired renal functions, acute kidney injury, or rapidly
progressive GN [6]. Even though it is common for renal
disease to manifest after a diagnosis of NHL, some studies
have shown renal involvement to be the first manifestation
identified [6].
In our report, we describe a rare case of B-cell NHL
MCL where the first presentation for medical attention was
because of renal involvement with hematuria. When our pa-
tient first presented, he had no significant lymphadenopathy
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of NHL, which may have been owing to the early stage
of the disease or patchy involvement of the bone mar-
row. The clinical picture with lymphadenopathy only man-
ifested three to four months after the renal manifestation.
In the absence of other supporting evidence at initial pres-
entation, results from a renal biopsy are very difficult to in-
terpret and mimic resolving acute GN, which is in keeping
with the clinical picture. Furthermore, the findings from
our patient’s renal biopsy with its immunofluorescence
pattern did not conform to any classic glomerular patho-
logical type but showed definitive evidence of proliferative
lesions with evidence of immune-mediated pathology. The
axillary lymph node biopsy was the definitive diagnostic in-
vestigation to confirm a diagnosis of MCL with associated
immune complex GN.
The rapidity with which our patient’s renal function and
urine sediment normalized within three months of starting
chemotherapy suggests a paraneoplastic renal manifest-
ation of MCL. One could hypothesize that the resolution
of the immunological process with chemotherapy also
resulted in the resolution of the immunological process
within the kidney.
There are only a handful of reported cases of MCL with
GN; our case is unusual because the first clinical presenta-
tion was due to renal involvement. MCL is a rare, aggres-
sive NHL; the few reported cases with GN have described
proliferative GN, focal segmental glomerulosclerosis, MCL
infiltration with AKI, and AKI due to tubulointerstitial in-
filtration of MCL [7]. The genetic hallmark of MCL is the
chromosomal translocation t(11;14), resulting in aberrant
expression of cyclin D1 [8]. The underlying pathogenesis
of NHL-associated GN is poorly understood. The focus is
currently on immune complexes containing tumor anti-
gens, which are deposited in the glomeruli [9]. Some litera-
ture even questions whether this glomerular involvement
is paraneoplastic in origin or results from a concurrent pri-
mary glomerular disease [10].
Studies regarding the treatment of NHL-associated GN
are limited. Current therapeutic management is therapeutic
ablation of the NHL, which will lead to spontaneous
resolution of the underlying GN [11]. In the management
of MCL, multiple chemotherapeutic regimens have been
used, including R-CHOP; R-bendamustine; and hyper-
fractionated cyclophosphamide, vincristine, doxorubicin,
and dexamethasone (Hyper-CVAD) [3].
Conclusions
It is important to have a high degree of suspicion when
patients present with acute immune complex GN with
no other identifiable cause because it could be the first
presentation of a NHL such as MCL. Although rare, screen-
ing for these malignancies is essential in the management of
these patients.Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
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